Submission of a UK Marketing Authorization Application for AMT-130 is expected in the third quarter of 2026 ~~ Type B Meeting with U.S. FDA ...
Morning Overview on MSN
MHRA recalls sertraline 100 mg batch after citalopram mix-up
The UK’s Medicines and Healthcare products Regulatory Agency has recalled a batch of Sertraline 100 mg tablets after ...
The reforms to the UK clinical trial regulation came into effect on 28 April 2026, but some experts still have reservations ...
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, today announced the U.K.
Dutch gene therapy company uniQure today announced it held a pre-submission meeting with the UK Medicines and Healthcare ...
The CEO of the Medicines and Healthcare products Regulatory Agency is set to leave the agency in 10 months. Ian Hudson’s decision means the agency faces the prospect of changing leaders while dealing ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Enflonsia (clesrovimab-cfor) for the ...
MHRA orders urgent recall after drug mix-up The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results